Research

The innovative technology behind xken health – the clinical proteome analysis – makes the test unique.

xken's clinical proteome analysis was developed over 20 years of clinical research

The basis of the xken health-Diagnostics are based on two decades of intensive research with international scientists. During this time, the technology was developed, the database was built and disease-specific protein patterns were defined. Clinical proteome analysis is performed by coupling capillary electrophoresis and mass spectrometry (CE-MS). It is always used in clinical studies. We will continue to generate disease-specific protein patterns in the future.

85.000

Samples and data sets

400

Scientific publications

100

clinical studies

With that from Prof. Dr. Harald Mischak developed and patented CE-MS technology, diseases are diagnosed early and precisely. By comparing the proteome with the previously defined disease-specific protein patterns in the database, the individual health status can be mapped.

The advantage for you is that the disease is detected at a time when appropriate therapy can stop the damage to the organs. Because the medicine of the future is an increasingly more individual medicine that is more strongly influenced by the idea of optimizing one's own body than by repairing temporary deficits.

Research into disease markers usually occurs through an initial inquiry from scientists from university hospitals. With every clinical study, new findings from proteome analysis expand to create and validate new clinical pictures. All data from the studies are fed into our database. Further studies are planned for your benefit in the future.

Our strength is that we can compare each sample with the many data sets in our database. Each disease has its own disease-specific protein pattern. Each sample contains thousands of proteins and their fragments (peptides). We analyze these qualitatively and quantitatively with your sample. xken's high precision is based not on a single disease marker, but on a combination of hundreds of disease markers.